SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories is currently trading at Rs 388.55, up by 5.05 points or 1.32% from its previous closing of Rs 383.50 on the BSE.

The scrip opened at Rs 384.95 and has touched a high and low of Rs 391.45 and Rs 382.00 respectively. So far 84870 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 611.75 on 04-Jan-2011 and a 52 week low of Rs 366.50 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs 406.00 and Rs 366.50 respectively. The current market cap of the company is Rs 16183.69 crore.

The promoters holding in the company stood at 63.75% while Institutions and Non-Institutions held 20.50% and 14.00% respectively.

Ranbaxy Laboratories has received US Food and Drug Administration (USFDA) approval to sell its generic drug acetaminophen in the world’s largest drug market. Acetaminophen is used for relief of headaches and other minor aches and pains.

Recently, Ranbaxy Laboratories had managed to capture about 2.5% market share in the generic Lipitor segment during initial days of its launch in the US.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×